BR9703373A - Análogos de vitamina d3 fluorados - Google Patents

Análogos de vitamina d3 fluorados

Info

Publication number
BR9703373A
BR9703373A BR9703373A BR9703373A BR9703373A BR 9703373 A BR9703373 A BR 9703373A BR 9703373 A BR9703373 A BR 9703373A BR 9703373 A BR9703373 A BR 9703373A BR 9703373 A BR9703373 A BR 9703373A
Authority
BR
Brazil
Prior art keywords
analogs
fluorinated vitamin
fluorinated
vitamin
Prior art date
Application number
BR9703373A
Other languages
English (en)
Inventor
Milan Radoje Uskokovic
Bernard Michael Hannessy
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9703373A publication Critical patent/BR9703373A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9703373A 1996-05-23 1997-05-23 Análogos de vitamina d3 fluorados BR9703373A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
BR9703373A true BR9703373A (pt) 1998-09-15

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703373A BR9703373A (pt) 1996-05-23 1997-05-23 Análogos de vitamina d3 fluorados

Country Status (30)

Country Link
US (1) US5888994A (pt)
EP (1) EP0808831B1 (pt)
JP (1) JP2858571B2 (pt)
KR (1) KR100237523B1 (pt)
CN (1) CN1081184C (pt)
AR (1) AR007240A1 (pt)
AT (1) ATE195514T1 (pt)
AU (1) AU720098B2 (pt)
BR (1) BR9703373A (pt)
CA (1) CA2204478C (pt)
CO (1) CO4840512A1 (pt)
CZ (1) CZ157997A3 (pt)
DE (1) DE69702812T2 (pt)
DK (1) DK0808831T3 (pt)
ES (1) ES2150719T3 (pt)
GR (1) GR3034832T3 (pt)
HR (1) HRP970274A2 (pt)
HU (1) HUP9700927A3 (pt)
IL (1) IL120842A0 (pt)
MA (1) MA24345A1 (pt)
NO (1) NO971934L (pt)
NZ (1) NZ314838A (pt)
PL (1) PL320131A1 (pt)
PT (1) PT808831E (pt)
SG (1) SG50831A1 (pt)
TR (1) TR199700418A3 (pt)
TW (1) TW374762B (pt)
UY (1) UY24563A1 (pt)
YU (1) YU19997A (pt)
ZA (1) ZA974334B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
US6100294A (en) * 1997-05-16 2000-08-08 Women And Infants Hospital Cyclic ether vitamin D3 compounds, 1α(OH) 3-epi-vitamin D3 compounds and uses thereof
WO1999012894A1 (en) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
WO2000051554A2 (en) * 1999-03-05 2000-09-08 Johns Hopkins University Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンd誘導体及び抗増殖薬の併用
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
CA2655499C (en) 2006-06-21 2015-10-27 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies
DK2148684T3 (da) 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
PT3342405T (pt) 2007-04-25 2019-12-02 Opko Ireland Global Holdings Ltd Libertação controlada 25-hidroxivitamina d
KR102125424B1 (ko) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 부갑상선 수준을 낮추기 위한 방법 및 조성물
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
CN106604733A (zh) 2014-08-07 2017-04-26 欧普科爱尔兰环球控股有限公司 利用25‑羟基维生素d的辅助疗法
IL290855B2 (en) 2016-03-28 2024-06-01 Eirgen Pharma Ltd Treatment methods using vitamin D

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
DE69304279T2 (de) * 1992-05-20 1997-02-20 Hoffmann La Roche Fluorierte Analoge Vitamins D3
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (pt) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
TR199700418A2 (xx) 1997-12-21
DE69702812T2 (de) 2001-01-25
KR970074763A (ko) 1997-12-10
EP0808831B1 (en) 2000-08-16
NZ314838A (en) 1998-01-26
CZ157997A3 (en) 1997-12-17
CN1169425A (zh) 1998-01-07
NO971934D0 (no) 1997-04-25
JP2858571B2 (ja) 1999-02-17
YU19997A (sh) 1999-07-28
TW374762B (en) 1999-11-21
DE69702812D1 (de) 2000-09-21
UY24563A1 (es) 2000-12-29
HUP9700927A3 (en) 1999-07-28
DK0808831T3 (da) 2001-01-02
IL120842A0 (en) 1997-09-30
PL320131A1 (en) 1997-11-24
CN1081184C (zh) 2002-03-20
PT808831E (pt) 2000-12-29
HRP970274A2 (en) 1998-04-30
EP0808831A2 (en) 1997-11-26
JPH1045712A (ja) 1998-02-17
US5888994A (en) 1999-03-30
ES2150719T3 (es) 2000-12-01
SG50831A1 (en) 1998-07-20
EP0808831A3 (en) 1999-02-03
CA2204478A1 (en) 1997-11-23
MX9703776A (es) 1998-06-30
CA2204478C (en) 2006-11-21
HU9700927D0 (en) 1997-07-28
CO4840512A1 (es) 1999-09-27
HUP9700927A2 (hu) 1998-01-28
ATE195514T1 (de) 2000-09-15
AU720098B2 (en) 2000-05-25
NO971934L (no) 1997-11-24
AU2357297A (en) 1997-11-27
GR3034832T3 (en) 2001-02-28
ZA974334B (en) 1997-11-24
KR100237523B1 (ko) 2000-01-15
AR007240A1 (es) 1999-10-27
TR199700418A3 (tr) 1997-12-21
MA24345A1 (fr) 1998-07-01

Similar Documents

Publication Publication Date Title
PT1124779E (pt) Analogos da vitamina d
PT808833E (pt) Analogos da vitamina d3
EE03832B1 (et) Heptapeptiidanaloogid
BR9703373A (pt) Análogos de vitamina d3 fluorados
NO990164D0 (no) Illudinanaloger nyttige som antitumormidler
PT1200399E (pt) Analogos de vitamina d3
DE69702261D1 (de) Sprachkodierung
BR9703385A (pt) Análogs fluorados da vitamina d3
DE69300355D1 (de) Fluor-enthaltende Vitamin-D3-Analogen.
DE59701251D1 (de) Brüstungsleiste
DK1137667T3 (da) GLP-1-analoger
ZA974332B (en) Fluorinated vitamin D3 analogs.
KR970015931U (ko) 분리형 신발
BR7600414U (pt) Unidade de salvamento simplificada
IT241213Y1 (it) Pozzetto per cavidotti
KR960007126U (ko) 등산 운동기
SG24096A1 (en) Fluorinated vitamin D3 derivative

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO TENDO EM VISTA O DESACORDO COM OS ARTS. 8O, 13, 24 E 25 DA LPI 9279/96